 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications |
| Sung-Ae Cho, Tae-Yun Sung |
|
Anesth Pain Med. 2022;17(2):121-131. Published online April 22, 2022 DOI: https://doi.org/10.17085/apm.22146 |
|
Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications Anesthesia and Pain Medicine. 2022;17(2):121-131  Is residual neuromuscular block following pancuronium a risk factor for postoperative pulmonary complications? Acta Anaesthesiologica Scandinavica. 1997;41(S110):156-158 Influence of sugammadex versus neostigmine for neuromuscular block reversal on the incidence of postoperative pulmonary complications: a meta-analysis of randomized controlled trials Perioperative Medicine. 2021;10(1): Residual neuromuscular block is a risk factor for postoperative pulmonary complications A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium Acta Anaesthesiologica Scandinavica. 1997;41(9):1095-1103 Predictive Study of Pharmacological Reversal for Residual Neuromuscular Blockade, Early and Late Postoperative Pulmonary Complications: A Prospective, Observational, Cohort Study . 2021; Sugammadex Versus Neostigmine for Neuromuscular Block Reversal and Postoperative Pulmonary Complications in Patients Undergoing Resection of Lung Cancer Journal of Cardiothoracic and Vascular Anesthesia. 2022;36(9):3626-3633 Reversal of residual neuromuscular block with neostigmine or sugammadex and postoperative pulmonary complications: a prospective, randomised, double-blind trial in high-risk older patients Anästhesie Nachrichten. 2021;3(4):22-23 Sugammadex as a reversal agent for neuromuscular block: an evidence-based review Core Evidence. 2013;57 Residual neuromuscular block in vulnerable patients: Obesity, obstructive sleep apnea and postoperative pulmonary complications Revista Española de Anestesiología y Reanimación (English Edition). 2019;66(5):237-240 Postoperative pulmonary complications and reversal agents British Journal of Anaesthesia. 2018;120(3):604 |
